We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARES icon
926
Ares Management
ARES
$28.8B
– –
-3,643
Closed -$486K
ASLE icon
927
AerSale
ASLE
$307M
– –
-12,746
Closed -$88.2K
ASTL icon
928
Algoma Steel
ASTL
$463M
– –
-23,016
Closed -$160K
ATEX icon
929
Anterix
ATEX
$1.83B
– –
-14,145
Closed -$560K
ATI icon
930
ATI
ATI
$26.3B
– –
-4,105
Closed -$228K
ATKR icon
931
Atkore
ATKR
$2.54B
– –
-7,544
Closed -$1.02M
ATRO icon
932
Astronics
ATRO
$3.47B
– –
-12,899
Closed -$215K
AVNS icon
933
Avanos Medical
AVNS
$1.17B
– –
-11,002
Closed -$219K
AXON
934
Axon Enterprise
AXON
$42.4B
– –
-888
Closed -$261K
BAC icon
935
Bank of America
BAC
$436B
– –
-71,021
Closed -$2.82M
BAH icon
936
Booz Allen Hamilton
BAH
$8.59B
– –
-5,709
Closed -$879K
BAND
937
Bandwidth Inc
BAND
$1.83B
– –
-13,847
Closed -$234K
BBSI icon
938
Barrett Business Services
BBSI
$995M
– –
-16,498
Closed -$541K
BBW icon
939
Build-A-Bear
BBW
$428M
– –
-9,759
Closed -$247K
BDN
940
Brandywine Realty Trust
BDN
$533M
– –
-10,428
Closed -$46.7K
BEN icon
941
Franklin Resources
BEN
$17.3B
– –
-70,705
Closed -$1.58M
BHF icon
942
Brighthouse Financial
BHF
$3.63B
– –
-16,057
Closed -$696K
BJ icon
943
BJs Wholesale Club
BJ
$12.1B
– –
-10,072
Closed -$885K
BNY
944
Bank of New York Mellon
BNY
$107B
– –
-10,680
Closed -$640K
BKH icon
945
Black Hills Corp
BKH
$5.68B
– –
-19,154
Closed -$1.04M
BLD
946
DELISTED
TopBuild
BLD
– –
-2,359
Closed -$909K
BOOT icon
947
Boot Barn
BOOT
$4.71B
– –
-5,633
Closed -$726K
BWA icon
948
BorgWarner
BWA
$13.1B
– –
-7,180
Closed -$231K
BXMT icon
949
Blackstone Mortgage Trust
BXMT
$2.8B
– –
-41,480
Closed -$723K
BXP icon
950
Boston Properties
BXP
$11B
– –
-4,996
Closed -$308K
36 37
38
39 40

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.